These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10621930)

  • 1. Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group.
    Ose L; Luurila O; Eriksson J; Olsson A; Lithell H; Widgren B
    Curr Med Res Opin; 1999; 15(3):228-40. PubMed ID: 10621930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
    Plosker GL; Dunn CI; Figgitt DP
    Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerivastatin gender effect: sub-analyses of results from a multinational, randomised, double-blind study. Cerivastatin Study Group.
    Ose L; Luurila O; Eriksson J; Olsson A; Lithell H; Widgren B
    Curr Med Res Opin; 2000; 16(2):80-7. PubMed ID: 10893651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
    Hunninghake DB
    Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
    Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
    Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
    Stein E; Isaacsohn J; Stoltz R; Mazzu A; Liu MC; Lane C; Heller AH
    Am J Cardiol; 1999 May; 83(10):1433-6. PubMed ID: 10335757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study.
    Hanefeld M; Deslypere JP; Ose L; Durrington PN; Farnier M; Schmage N
    J Int Med Res; 1999; 27(3):115-29. PubMed ID: 10505301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia.
    Simons LA
    Am J Cardiol; 2002 Oct; 90(7):737-40. PubMed ID: 12356387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigators.
    Rubinstein A; Maritz FJ; Soule SG; Markel A; Chajek-Shaul T; Maislos M; Tal S; Stolero D
    J Cardiovasc Risk; 1999 Dec; 6(6):399-403. PubMed ID: 10817086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group.
    Betteridge DJ
    Int J Clin Pract; 1999 Jun; 53(4):243-50. PubMed ID: 10563066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
    Stein E
    Am J Cardiol; 1998 Aug; 82(4B):40J-46J. PubMed ID: 9737645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC; Chen CH; Tsao HM; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
    Isaacsohn J; Insull W; Stein E; Kwiterovich P; Patrick MA; Brazg R; Dujovne CA; Shan M; Shugrue-Crowley E; Ripa S; Tota R;
    Clin Cardiol; 2001 Sep; 24(9 Suppl):IV1-9. PubMed ID: 11594407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
    Hunninghake D; Insull W; Knopp R; Davidson M; Lohrbauer L; Jones P; Kafonek S
    Am J Cardiol; 2001 Sep; 88(6):635-9. PubMed ID: 11564386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
    Saunders E; Ferdinand K; Yellen LG; Tonkon MJ; Krug-Gourley S; Poland M
    J Natl Med Assoc; 2000 Jul; 92(7):319-26. PubMed ID: 10946527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].
    Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
    Rev Med Interne; 1999 Aug; 20 Suppl 3():393s-398s. PubMed ID: 10480191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
    Farnier M
    Am J Cardiol; 1998 Aug; 82(4B):47J-51J. PubMed ID: 9737646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia.
    Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
    Clin Ther; 1998; 20(3):539-48. PubMed ID: 9663369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
    Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
    Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.